These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32666003)

  • 1. Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer.
    Morgentaler A; Traish AM
    Investig Clin Urol; 2020 Jul; 61(4):452-454. PubMed ID: 32666003
    [No Abstract]   [Full Text] [Related]  

  • 2. Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer.
    Kim JW
    Investig Clin Urol; 2020 May; 61(3):242-249. PubMed ID: 32377599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes.
    Taneja SS
    J Urol; 2013 Oct; 190(4):1246. PubMed ID: 24029310
    [No Abstract]   [Full Text] [Related]  

  • 4. Testosterone replacement therapy in prostate cancer patients: is it safe?
    Umbas R; Sugiono M
    Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone therapy and prostate cancer--safety concerns are well founded.
    Klotz L
    Nat Rev Urol; 2015 Jan; 12(1):48-54. PubMed ID: 25563848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
    Seftel AD
    J Urol; 2015 Jun; 193(6):1985-6. PubMed ID: 25986797
    [No Abstract]   [Full Text] [Related]  

  • 7. Androgens and depression: a review and update.
    Nead KT
    Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):175-179. PubMed ID: 30958398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes.
    Kaplan AL; Hu JC
    Urology; 2013 Aug; 82(2):321-6. PubMed ID: 23706552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of androgen supplementation therapy on the prostate.
    Kaufman JM
    Aging Male; 2003 Sep; 6(3):166-74. PubMed ID: 14628497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Pro.
    Morgentaler A
    J Urol; 2016 Oct; 196(4):985-8. PubMed ID: 27449261
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prostate carcinoma and testosterone: risks and controversies].
    Rhoden EL; Averbeck MA
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):956-62. PubMed ID: 20126847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen replacement therapy and prostate safety.
    Morales A
    Eur Urol; 2002 Feb; 41(2):113-20. PubMed ID: 12074396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of fires and frying pans.
    Roth RB; Hess E; Kaminsky AF
    JAMA; 2015 Feb; 313(6):632. PubMed ID: 25668278
    [No Abstract]   [Full Text] [Related]  

  • 15. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
    Meza J; Weaver K; Martin S
    Am Fam Physician; 2013 Oct; 88(8):Online. PubMed ID: 24364582
    [No Abstract]   [Full Text] [Related]  

  • 16. Testosterone replacement therapy and prostate cancer: a word of caution.
    Brand TC; Canby-Hagino E; Thompson IM
    Curr Urol Rep; 2007 May; 8(3):185-9. PubMed ID: 17459266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring androgen replacement therapy: testosterone and prostate safety.
    Morales A
    J Endocrinol Invest; 2005; 28(3 Suppl):122-7. PubMed ID: 16042371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
    Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer and Testosterone Replacement Therapy--What is the Risk?
    Carson CC; Kirby R
    J Urol; 2015 Dec; 194(6):1527-8. PubMed ID: 26386278
    [No Abstract]   [Full Text] [Related]  

  • 20. [Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?].
    Castillo OA; López-Fontana G; Vidal-Mora I; López Laur JD
    Medwave; 2015 Apr; 15(3):e6115. PubMed ID: 25919660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.